FindTrial
Sign In

Comparison of surgical and non-surgical treatment for malignant infiltrative renal masses

Comparison of surgical and non-surgical treatment for malignant infiltrative renal masses

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050393
Enrollment
Unknown
Registered
2021-08-27
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal cancer

Interventions

Surgical treatment group:Nil
Non-surgical treatment group:Nil

Sponsors

Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. 18-80 years old; 2. Infiltrative renal masses on CT or MRI; 3. It is confirmed as malignancy by surgery or puncture.

Exclusion criteria

Exclusion criteria: Data loss.

Design outcomes

Primary

MeasureTime frame
Overall survival (OS);—

Secondary

MeasureTime frame
Progression-free survival (PFS);Cancer-specific survival (CSS);Quality of life score;—

Countries

China

Contacts

Public ContactZhang Feng

Shengjing Hospital of China Medical University

billoctober@163.com+86 18940254543

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026